XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification

Molecular Carcinogenesis

Volumn 51, Issue 5, 2012, Pages 422-432

  Zou, Bing ^a,b   Chim, Chor S ^b   Pang, Roberta ^b   Zeng, Hui ^a   Dai, Yun ^b   Zhang, Rongxin ^b   Lam, Colin S C ^b   Tan, Victoria P Y ^b   Hung, Ivan F N ^b   Lan, Hui Y ^c   Wong, Benjamin C Y ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Colon cancer; Gastric cancer; P53; XAF1

Indexed keywords

MESSENGER RNA; PROTEIN P53; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; COLON CANCER; DNA DAMAGE; DOWN REGULATION; GENE INTERACTION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 84859776957     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20807     Document Type: Article

References (26)

1. Liston P, Fong WG, Kelly NL, et al. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol 2001; 3: 128-133.
2. Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: Why XIAP is the black sheep of the family. EMBO Rep 2006; 7: 988-994. Review.
3. LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, Korneluk RG. IAP-targeted therapies for cancer. Oncogene 2008; 27: 6252-6275. Review.
4. Arora V, Cheung HH, Plenchette S, Micali OC, Liston P, Korneluk RG. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex. J Biol Chem 2007; 282: 26202-26209.
5. Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 2000; 70: 113-122.
6. Zou B, Chim CS, Zeng H, et al. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology 2006; 131: 1835-1843.
7. Lee MG, Huh JS, Chung SK, et al. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: Implication for attenuated p53 response to apoptotic stresses. Oncogene 2006; 25: 5807-5822.
8. Wang J, Peng Y, Sun YW, et al. All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer. Gastroenterology 2006; 130: 747-758.
9. Yu L, Wang J, Zou B, et al. XAF1 mediates apoptosis through an extracellular signal-regulated kinase pathway in colon cancer. Cancer 2007; 109: 1996-2003.
10. Wang J, He H, Yu L, et al. HSF1 down-regulates XAF1 through transcriptional regulation. J Biol Chem 2006; 281: 2451-2459.
11. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-310.
12. Jin S, Levine AJ. The p53 functional circuit. J Cell Sci 2001; 114: 4139-4140.
13. Harris SL, Levine AJ. The p53 pathway: Positive and negative feedback loops. Oncogene 2005; 24: 2899-2908.
14. Strahl-Bolsinger S, Hecht A, Luo K, Grunstein M. SIR2 and SIR4 interactions differ in core and extended telomeric heterochromatin in yeast. Genes Dev 1997; 11: 83-93.
15. Vogelstein B, Kinzler KW. X-rays strike p53 again. Nature 1994; 370: 174-175.
16. Lavin MF, Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ 2006; 13: 941-950.
17. Russo A, Bazan V, Iacopetta B, et al. The p53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: Influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 2005; 30: 7518-7528.
18. Steele RJ, Lane DP. p53 in cancer: A paradigm for modern management of cancer. Surgeon 2005; 3: 197-205.
19. Lakin ND, Jackson SP. Regulation of p53 in response to DNA damage. Oncogene 1999; 18: 7644-7655.
20. Apella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 2001; 268: 2764-2772.
21. Saito S, Yamaguchi H, Higashimoto Y, et al. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem 2003; 278: 37536-37544.
22. Li M, Luo J, Brooks CL, Gu W. Acetylation of p53 inhibits its ubiguition by Mdm2. J Biol Chem 2002; 52: 50607-50611.
23. Oda K, Arakawa H, Tanaka T, et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phsphorylated p53. Cell 2000; 102: 849-862.
24. Mayo LD, Seo YR, Jackson MW, et al. Phosphorylation of human p53 at Ser46 determines promoter selection and whether apoptosis is attenuated or amplified. J Biol Chem 2005; 280: 25953-25959.
25. Cecchinelli B, Lavra L, Rinaldo C, et al. Repression of the anti-apoptotic molecule galectin-3 by HIPK2-activated p53 is required for p53-induced apoptosis. Mol Cell Biol 2006; 26: 4746-4757.
26. Zhang W, Guo Z, Jiang B, et al. Identification of a functional p53 responsive element within the promoter of XAF1 gene in gastrointestinal cancer cells. Int J Oncol 2010; 36: 1031-1037.